Atrial arrhythmogenicity in aged Scn5a+/∆KPQ mice modeling long QT type 3 syndrome and its relationship to Na+ channel expression and cardiac conduction
- First Online:
- 627 Downloads
Recent studies have reported that human mutations in Nav1.5 predispose to early age onset atrial arrhythmia. The present experiments accordingly assess atrial arrhythmogenicity in aging Scn5a+/∆KPQ mice modeling long QT3 syndrome in relationship to cardiac Na+ channel, Nav1.5, expression. Atrial electrophysiological properties in isolated Langendorff-perfused hearts from 3- and 12-month-old wild type (WT), and Scn5a+/∆KPQ mice were assessed using programmed electrical stimulation and their Nav1.5 expression assessed by Western blot. Cardiac conduction properties were assessed electrocardiographically in intact anesthetized animals. Monophasic action potential recordings demonstrated increased atrial arrhythmogenicity specifically in aged Scn5a+/ΔKPQ hearts. These showed greater action potential duration/refractory period ratios but lower atrial Nav1.5 expression levels than aged WT mice. Atrial Nav1.5 levels were higher in young Scn5a+/ΔKPQ than young WT. These levels increased with age in WT but not Scn5a+/ΔKPQ. Both young and aged Scn5a+/ΔKPQ mice showed lower heart rates and longer PR intervals than their WT counterparts. Young Scn5a+/ΔKPQ mice showed longer QT and QTc intervals than young WT. Aged Scn5a+/ΔKPQ showed longer QRS durations than aged WT. PR intervals were prolonged and QT intervals were shortened in young relative to aged WT. In contrast, ECG parameters were similar between young and aged Scn5a+/ΔKPQ. Aged murine Scn5a+/ΔKPQ hearts thus exhibit an increased atrial arrhythmogenicity. The differing Nav1.5 expression and electrocardiographic indicators of slowed cardiac conduction between Scn5a+/ΔKPQ and WT, which show further variations associated with aging, may contribute toward atrial arrhythmia in aged Scn5a+/ΔKPQ hearts.
KeywordsLQT3 syndrome Atrial arrhythmogenicity Genetically modified mice Na channels Age Arrhythmia Sodium channel Mouse Electrophysiology Excitation
Atrial arrhythmia, of which the most common form is atrial fibrillation (AF), is particularly common in the elderly. Genetically normal patients show a median age of onset of AF of 75 years with ∼70% of such patients aged between 65 and 85 years . There have been recent studies implicating an involvement of cardiac ion channels in the development of AF [5, 6, 7]. Thus, long QT syndrome (LQTS) patients show an earlier than normal onset of AF , typically at age ∼50 ± 14 years . In particular, variants of the SCN5A gene encoding the cardiac Na+ channel (Nav1.5) have been clinically associated with the presence of AF. A study resequencing the SCN5A coding regions reported that 6% of 375 patients with AF showed variations in SCN5A . Roles for Nav1.5 in the development of atrial arrhythmia are further implicated by the SCN5A polymorphism, H558R, prevalent in 20% of the population, also being a risk factor for AF .
Of the >200 such SCN5A mutations reported , the gain of function mutation Scn5a+/ΔKPQ involves deletion of the three conserved amino acids, KPQ1505–1507. It has been clinically associated with long QT syndrome type 3 (LQT3). This in turn is associated with a potentially fatal ventricular arrhythmogenic tendency that increases with age and that becomes evident within the first four decades of life [50, 51]. Loss of function mutations in SCN5A are associated with Brugada syndrome (BrS), a cardiac disorder characterized by an elevated ST segment in electrocardiographic (ECG) waveform . Furthermore, a proportion of patients that harbor various losses and gain of function SCN5A mutations all demonstrate AF. Thus, 10–30% of BrS patients show increased propensities to atrial fibrillation [4, 26, 31, 32]. In contrast, Benito et al.  described a family, with eight members across three generations, showing both early onset AF and LQT3 associated with a mutant SCN5A gene involving the Y1795C mutation. Similarly, early onset AF in a Japanese family has been related to a novel gain-of-function, M1875T, mutation in SCN5A .
Such similarities in clinical outcome as a result of differing SCN5A mutations are consistent with reports of overlap syndrome in patients with LQT3 and BrS; conversely, some mutations can be associated with more than one phenotype in particular patients [42, 45]. For example, a single Na+ channel mutation involving deletion of lysine 1500, ΔK1500, is associated with not only LQTS but also BrS and conduction system disease . Also the insertion D1795 induces both LQTS and BrS and has been shown to result in a 62% reduction of channel expression . Finally, clinical phenotypes that overlap with those observed in BrS have also been reported to occur in patients carrying the SCN5A+/ΔKPQ mutation .
The physiological relationships between the underlying SCN5A+/ΔKPQ mutation and such related ventricular arrhythmic phenotypes have been investigated using a murine Scn5a+/ΔKPQ model . Murine systems have also been used to study atrial arrhythmogenicity [25, 48]. However, very few experimental studies have related SCN5A mutations to alterations in atrial arrhythmogenicity. One such report described a reduced atrial arrhythmogenicity in Scn5a+/ΔKPQ murine hearts modeling LQT3 syndrome . However, it did not investigate the effects of aging. Nevertheless, this is an important factor contributing to the variable penetrance of LQT3 .
This study accordingly proceeds to explore for the development of atrial arrhythmogenic properties with aging, comparing these to action potential waveform and refractory periods, Nav1.5 expression, and electrocardiographic properties in Scn5a+/∆KPQ and WT mice for the first time. We demonstrated that Nav1.5 protein expression was affected by age and genotype in a manner that would be compatible with a phenotypic overlap and attributed these findings to evidence for a compromised Nav1.5 function.
Wild-type (WT) and Scn5a+/∆KPQ mice, with an inbred 129/Sv genetic background, were housed in cages at 21 ± 1°C with 12 h light/dark cycles. The mice, studied at ages of either 3 months (young) and 12 months (aged), were killed by cervical dislocation, in compliance with the UK Animals (Scientific Procedures) Act 1986.
Isolation, cannulation, and perfusion of mouse hearts
For the purpose of Na+ channel extraction and experiments on isolated Langendorff preparations, hearts were excised and immediately placed in ice-cold bicarbonate Krebs–Henseleit (KH) buffer solution containing (mM): 119 NaCl, 25 NaHCO3, 4.0 KCl, 1.2 KH2PO4, 1.0 MgCl2, 1.8 CaCl2, 10 glucose, and 2.0 sodium pyruvate (pH 7.4). The KH buffer was bubbled with 95% O2/5% CO2 (British Oxygen Company, Manchester, UK) for 20 min prior to addition of 1.8 mM CaCl2. The bubbling with 95% O2/5% CO2 was continued during the experiments themselves. A 2-mm length of the aorta was cannulated and held in place with an aneurysm clip. The hearts were perfused with KH buffer warmed to 37°C until they regained a healthy pink appearance and resumed spontaneous activity. Perfusion was continued for a further 10 min before either electrophysiological studies or protein extraction.
Monophasic action potential recording
Hearts were excised and cannulated as described above, and AV nodes were ablated. Left atrial monophasic action potentials (MAPs) were recorded using a miniaturized MAP electrode tip (Linton Instruments, Harvard Apparatus, UK). A platinum stimulating electrode (1 mm inter-pole spacing) was placed on the right atrium. Square wave stimuli (Grass S48 stimulator, Grass-Telefactor, Slough, UK) of 2 ms duration and ×1.5 threshold were applied at a cycle length of 125 ms for 10 min until MAP waveforms had stable baselines, rapid upstroke phases, and smooth repolarization phases. Action potential durations were determined from regular pacing. Programmed electrical stimulation (PES) was used to assess arrhythmogenicity and refractoriness. This consisted of cycles of stimulus trains of eight S1 beats delivered at 8 Hz at ×1.5 threshold followed by an S2 extrastimulus, at progressively shorter S1S2 coupling intervals until the S2 no longer elicited an action potential. Arrhythmia was defined as three or more consecutive premature atrial waveforms.
Nav1.5 protein preparation
After perfusion, left atrial appendages were removed and clamp-frozen. The tissue was homogenized in liquid nitrogen with a mortar and pestle on dry ice. Homogenates were resuspended in a solution consisting of (in mM) 50 Tris–HCl, 10 NaCl, 320 sucrose, 5 EDTA, and 2.5 EGTA (pH 7.4) and placed into Eppendorf tubes and gently resuspended with a pipette tip. Once thawed, but when still cool, the samples were placed on ice. Samples were blade homogenized for 20 s each, rinsing the blade thoroughly between samples. The preparation was lysed with 1% Triton X100 and rotated for 1 h at 4°C. After incubation, the samples were subjected to centrifugation at 12,000×g and 4°C. The supernatant was decanted into a sample loading buffer (NuPAGE, Invitrogen, Paisley, UK) to obtain a 1:4 dilution. Samples were boiled at 70°C for 10 min, flash frozen and stored at −80°C.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis and Western blots
Five micrograms of total protein was loaded per lane (NuPAGE gels) as was measured in triplicate with Bradford Assay (Bio-Rad Laboratories Ltd, Herts, UK) alongside a molecular weight marker (SeeBlue Plus prestained standard, Paisley, UK). Duplicate gels were subjected to Imperial Blue Protein stain (Thermo Scientific, Rockford, IL, USA) to confirm equal loading. NuPAGE electrophoresis tanks were used to run sodium dodecyl sulfate polyacrylamide gel electrophoresis at 100 mA for 3 h. Protein bands were transferred onto nitrocellulose membrane by a NuPAGE blotting system for 2 h. Membranes were blocked overnight in 5% milk–Tris-buffered saline–1% Tween, followed by several rinses prior to incubation with Nav1.5 antibody (1:500, ASC005, Caltag Medisystems, Alomone, Israel). The membranes were incubated with secondary antibody conjugated with horseradish peroxidase from Sigma-Aldrich (Poole, Dorset, UK) and rinsed five times. Western blot development was performed with Amersham ECL reagents (Amersham Biosciences, Amersham, Bucks, UK).
Mice were anesthetized with Avertin (Sigma) 240 mg/kg at a dose rate of 0.1 ml/10 g body weight. Injection was given intraperitoneally with a 27G hypodermic needle into the left peritoneal cavity. Lead II ECG recordings were acquired using LabChart software (ADI Instruments, Chalgrove, Oxfordshire, UK). This incorporated algorithms for determinations of ECG parameters, including RR intervals, P wave durations, PR intervals, QRS intervals and QT durations. It also included QTc intervals derived from the QT interval corrected for variations in the RR interval [19, 33]
Data analysis and statistics
Data was acquired using a model 1401 interface, analysed with Spike version 5.2 (Cambridge Electronic Design, Cambridge, UK) and are presented as means ± standard errors of the means. Image J was used for densitometry (NIH, Bethesda, MD, USA). Comparisons were performed by a one-way analysis of variance (ANOVA) or Fisher’s exact test where appropriate, with SPSS software (SPSS UK, Woking, Surrey, UK). For all tests, young and aged mice of the same genotype were compared followed by tests between WT and Scn5a+/∆KPQ of the same age. Statistical significance was assumed at P < 0.05.
The Scn5a+/∆KPQ mutation abolishes normal increases in atrial refractory periods with age and results in high action potential duration/atrial effective refractory period (APD/AERP) ratios
Figure 2b demonstrates that the AERP was prolonged in aged WT compared to young WT (P < 0.001), consistent with previous findings in murine hearts that atrial refractory periods increase with advancing age. This would be expected to offset any arrhythmogenic effects of corresponding decreases in conduction velocity known to occur with age [22, 23, 30]. In contrast, young and aged Scn5a+/ΔKPQ atria showed similar AERPs. Young WT and young Scn5a+/ΔKPQ hearts showed indistinguishable AERPs. However, AERPs in aged WT hearts were significantly prolonged compared to aged Scn5a+/ΔKPQ (P < 0.01; n = 7 in each group).
Figure 2c summarizes APD/AERP ratios, previously used to assess atrial arrhythmogenicity , derived from the APD and AERP findings summarized above. Young Scn5a+/ΔKPQ hearts showed increased APD/AERP ratios compared to young WT hearts (P < 0.05). However, whereas APD/AERP ratios decreased with age in WT (P < 0.01), these remained the same in Scn5a+/ΔKPQ hearts, with values approaching unity and significantly high ratios in aged Scn5a+/ΔKPQ relative to aged WT (P < 0.001). This was consistent with the increased arrhythmic tendency found specifically in aged Scn5a+/ΔKPQ observed in the experiments that followed.
Significant increases in atrial arrhythmogenic tendency are specific to aged Scn5a+/ΔKPQ mice
Incidence of atrial arrhythmia
Scn5a +/ ΔKPQ
3 of 7c
0 of 6a
0 of 7b
6 of 6a,b,c
The Scn5a+/ΔKPQ mutation results in abnormal changes in Na+ channel expression levels with age
The young WT mice showed lower levels of Nav1.5 expression than did the aged WT, indicating increases in expression with aging (P < 0.01). In contrast, both young and aged Scn5a+/ΔKPQ atria contained similar levels of Nav1.5. Comparisons between genotypes similarly demonstrated that young Scn5a+/ΔKPQ mice showed higher Nav1.5 expression than did young WT (P < 0.05). Conversely, aged Scn5a+/ΔKPQ atria showed decreased Nav1.5 expression compared to aged WT (P < 0.05). Thus, Scn5a+/ΔKPQ atria failed to show the age dependent expression patterns demonstrated in WT mice.
Scn5a+/∆KPQ hearts show altered conduction properties
ECG parameters compared in WT and Scn5a+/ΔKPQ
RR interval, ms
141.18 ± 3.03 (6)a
129.87 ± 4.49 (5)b
161.12 ± 1.32 (5)a
152.54 ± 8.18 (6)b
426.51 ± 8.73 (6)c
464.54 ± 16.73 (5)d
372.75 ± 3.05 (5)c
399.03 ± 20.71 (6)d
PR interval (ms)
45.00 ± 1.93 (5)e,f
37.31 ± 1.92 (6)e,g
50.45 ± 0.83 (5)f
48.09 ± 1.46 (6)g
P wave duration (ms)
11.40 ± 0.77 (6)
13.42 ± 1.19 (5)
16.59 ± 2.60 (5)
15.74 ± 1.50 (6)
QRS interval (ms)
11.48 ± 0.93 (6)
10.75 ± 0.24 (5)h
12.88 ± 0.68 (5)
15.70 ± 1.91 (6)h
QT interval (ms)
33.03 ± 1.44 (6)i,j
44.08 ± 9.79 (5)i
45.89 ± 2.49 (5) j
47.81 ± 2.79 (6)
QTc interval (ms)
27.95 ± 1.40 (6)k,l
37.56 ± 4.07 (5)k
37.31 ± 1.45 (5)l
38.83 ± 2.21 (6)
The present experiments compared changes in basic electrophysiological properties and their relationship to the development or otherwise of atrial arrhythmogenic properties in aging murine Scn5a+/ΔKPQ and WT hearts. They extend previous reports on atrial  and ventricular [41, 44] arrhythmogenicity in Scn5a+/ΔKPQ hearts that, however, did not explore effects of aging on these properties. An initial determination of the normal changes in WT provided controls against which to assess the presence or absence of abnormal changes in the Scn5a+/ΔKPQ hearts. MAP records were first obtained from Langendorff-perfused hearts to explore for arrhythmogenic properties in response to both regular and extrasystolic imposed stimulation. These properties were then compared with the features of action potential recovery as reflected in their durations and refractory periods. The presence or absence of arrhythmogenicity was then related to the results of Western blot determinations of cardiac Na+ channel (Nav1.5) expression levels performed for the first time in the Scn5a+/ΔKPQ system. These in turn were related to electrocardiographic assessments of in vivo cardiac conduction properties in anesthetized animals.
The MAP studies in isolated Langendorff-perfused hearts assessed the frequencies of atrial arrhythmogenesis in young and aged, WT and Scn5a+/ΔKPQ, hearts using a PES procedure. They demonstrated for the first time that aged Scn5a+/ΔKPQ hearts showed an increased atrial arrhythmogenicity compared to any of the other three groups. This took place despite an absence of any detectable differences in atrial action potential durations to 90% recovery (APD). The latter finding rules out arrhythmogenic mechanisms involving action potential recovery previously implicated in the ventricular arrhythmogenicity shown by Scn5a+/ΔKPQ on earlier occasions . Whereas refractory periods in young WT and young Scn5a+/ΔKPQ were closely similar, they sharply increased with age in WT, consistent with previous reports ; however, they did not do so in Scn5a+/ΔKPQ. Consequently, Scn5a+/ΔKPQ hearts showed shorter refractory periods and greater APD/AERP ratios than aged WT. Both of these have been previously introduced as indices of ventricular  as well as atrial  arrhythmogenicity, respectively. These results were thus consistent with the higher inducibility of atrial arrhythmias by programmed atrial stimulation that was observed in aged Scn5a/ΔKPQ mice.
These findings were then compared with results from complementary examinations of Nav1.5 protein expression in the experimental groups. Such Western blot studies directly measure specific protein levels as opposed to indirect measures involving messenger RNA (mRNA). These demonstrated that Nav1.5 channel expression increased with age and genotype, complementing previous electrophysiological reports of altered cardiac Ca2+ and K+ channel expression with age in WT [11, 21]. Thus, young WT showed relatively low levels of Nav1.5 expression, but these markedly increased with normal aging. In contrast, young Scn5a+/ΔKPQ showed higher Nav1.5 expression than young WT but then showed no further increases with age. Aged Scn5a+/ΔKPQ consequently showed substantially lower Nav1.5 expression than aged WT.
The latter findings were compatible with the final, electrocardiographic, results. These similarly revealed genotype- and age-specific phenotypic alterations in intact anesthetized WT and Scn5a+/ΔKPQ mice. Firstly, young Scn5a+/ΔKPQ mice showed longer QT and QTc intervals than did young WT, consistent with the LQT3 condition. Secondly, even young WT and young Scn5a+/ΔKPQ mice differed in those ECG features that bore on atrial pacemaker and AV conduction properties. Young and aged Scn5a+/ΔKPQ mice had lower heart rates and slower AV conduction than their respective WT counterparts. In addition, aged Scn5a+/ΔKPQ mice showed depressed intra-ventricular conduction relative to aged WT. Finally, WT and Scn5a+/ΔKPQ also showed differing alterations with age. Thus, while PR and QT intervals change with age in WT mice, this was not evident in Scn5a+/ΔKPQ hearts.
Comparisons between these findings were consistent with a hypothesis in which small APD/AERP ratios together with high levels of Nav1.5 expression might balance the arrhythmic effects of a slowing of conduction with age. This could be related to a progressive interstitial fibrosis that has been shown to occur in the atria of humans [12, 43] and animals [1, 17]; the latter includes mice with mutations involving Scn5a . Such fibrosis is also associated with clinical AF [24, 29]. In addition, localized alterations in AERP shown to increase with age would be expected to accentuate dispersions of intra-atrial refractoriness . All these processes would be expected to cause a heterogeneous slowing of atrial conduction and consequent age-related increases in atrial arrhythmic tendency.
In such a situation, the observed increases in Nav1.5 could protect against atrial arrhythmia in aged WT. Thus, WT hearts were not arrhythmogenic: APD/AERP ratios were smaller for aged WT than young WT, while there was a higher Nav1.5 expression in aged WT relative to young WT. In contrast, aged Scn5a+/ΔKPQ were more arrhythmogenic than the remaining groups. This was consistent with their higher APD/AERP ratios and reduced Nav1.5 expression levels relative to aged WT. Finally, these results additionally relate the greater arrhythmogenecity of aged Scn5a+/ΔKPQ compared to young Scn5a+/ΔKPQ, despite similar APD/AERP ratios and AERP values, to their failure to increase Nav1.5 expression with age unlike WT. Thus, despite possessing a gain of function mutation, aged Scn5a+/ΔKPQ atria showed reduced Nav1.5 expression levels and high APD/AERP ratios. This may have resulted in an atrial arrhythmogenicity that was prevented by the increase in Nav1.5 expression with age shown by the WT.
Such changes could also involve altered expression of a range of genes and ion channels, besides Nav1.5. Thus, ventricular mRNA expression profiles in studies of human BrS associated with Na+ channelopathy suggested remodeled K+ and Ca2+ in addition to Na+-channel expression . For example, their reduced expression of Kv4.3 encoding the principal Ito subunit, increased transcript expression of Nav2.1, and increased 2P-channel expression would tend to compensate for the Nav1.5 underexpression observed in BrS-affected individuals. Conditions of atrial fibrillation or tachycardia results in reductions of transient outward K+ current (Ito), downregulation of ICaL pore-forming α-subunit mRNA, and increased expression of Kir2.1 mRNA and protein . Furthermore, there is evidence associating BrS with such atrial remodeling .
In demonstrating that aged Scn5a+/ΔKPQ mice show an increased propensity to atrial arrhythmia, the findings in this study thus recapitulate clinical situations of phenotypic overlap between LQTS and BrS. A loss of Nav1.5 function may reflect haploinsufficiency and impaired intracellular trafficking reducing surface level expression . The reduction in Nav1.5 protein expression observed here is compatible with such a possibility. This in turn may be the cause of a situation resembling the case of the Brugada mouse model in which a loss of Na+ channel expression results in both ventricular  and atrial arrhythmogenic properties [27, 28]. Such a notion would be compatible with the electrocardiographic evidence for reduced pacemaker activity and delayed conduction in both young and aged Scn5a+/ΔKPQ relative to WT hearts. These also parallel reduced SA node activity and slowed AV conduction that has been reported in BrS patients . Taken together, these findings could therefore account for phenotypic overlaps between LQT3 and BrS patients  besides demonstrating the existence of a complex dynamic interplay between aging, ion channel expression, and cardiac tissue excitability.
This study was supported by grants from the Wellcome Trust and the British Heart Foundation.
Conflicts of interest
The authors declare that they have no conflict of interest.
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.